Results of prescription event monitoring study of salmeterol.
作者信息
Mann R D
出版信息
BMJ. 1994 Oct 15;309(6960):1018. doi: 10.1136/bmj.309.6960.1018b.
Abstract
摘要
相似文献
1
Results of prescription event monitoring study of salmeterol.沙美特罗处方事件监测研究结果。
BMJ. 1994 Oct 15;309(6960):1018. doi: 10.1136/bmj.309.6960.1018b.
2
Bronchodilator treatment in asthma.哮喘的支气管扩张剂治疗
BMJ. 1993 Sep 11;307(6905):683. doi: 10.1136/bmj.307.6905.683-b.
3
Age- and gender-specific asthma death rates in patients taking long-acting beta2-agonists: prescription event monitoring pharmacosurveillance studies.使用长效β2受体激动剂患者的年龄和性别特异性哮喘死亡率：处方事件监测药物警戒研究
Drug Saf. 2001;24(6):475-81. doi: 10.2165/00002018-200124060-00005.
4
Salmeterol: a study by prescription-event monitoring in a UK cohort of 15,407 patients.沙美特罗：在英国一个15407名患者的队列中进行的处方事件监测研究。
J Clin Epidemiol. 1996 Feb;49(2):247-50. doi: 10.1016/0895-4356(95)00555-2.
5
Bronchodilator treatment in asthma.哮喘的支气管扩张剂治疗
BMJ. 1993 Aug 14;307(6901):446. doi: 10.1136/bmj.307.6901.446.
6
Bronchodilator treatment in asthma. Increase in deaths during salmeterol treatment unexplained.哮喘中的支气管扩张剂治疗。沙美特罗治疗期间死亡人数增加，原因不明。
BMJ. 1993 Jun 12;306(6892):1610-1. doi: 10.1136/bmj.306.6892.1610-c.
7
Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment.施立稳全国性监测研究：沙美特罗与沙丁胺醇在需要常规支气管扩张剂治疗的哮喘患者中的比较
BMJ. 1993 Apr 17;306(6884):1034-7. doi: 10.1136/bmj.306.6884.1034.
8
Bronchodilator treatment in asthma. Manufacturers underestimate mortality from asthma.哮喘中的支气管扩张剂治疗。制造商低估了哮喘死亡率。
BMJ. 1993 Jun 12;306(6892):1610; author reply 1611. doi: 10.1136/bmj.306.6892.1610.
9
Bronchodilator treatment in asthma. Study too small to detect increase in deaths.哮喘中的支气管扩张剂治疗。研究规模过小，无法检测到死亡人数的增加。
BMJ. 1993 Jun 12;306(6892):1610; author reply 1611. doi: 10.1136/bmj.306.6892.1610-a.
10
Bronchodilator treatment in asthma. Regular treatment with beta agonists remains unevaluated.哮喘中的支气管扩张剂治疗。β受体激动剂的常规治疗仍未得到评估。
BMJ. 1993 Jun 12;306(6892):1610; author reply 1611. doi: 10.1136/bmj.306.6892.1610-b.
本文引用的文献
1
Bronchodilator treatment in asthma. Manufacturers underestimate mortality from asthma.哮喘中的支气管扩张剂治疗。制造商低估了哮喘死亡率。
BMJ. 1993 Jun 12;306(6892):1610; author reply 1611. doi: 10.1136/bmj.306.6892.1610.
2
Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment.施立稳全国性监测研究：沙美特罗与沙丁胺醇在需要常规支气管扩张剂治疗的哮喘患者中的比较
BMJ. 1993 Apr 17;306(6884):1034-7. doi: 10.1136/bmj.306.6884.1034.
Zotero 插件